Shkreli will lose his Wu-Tang album—judge orders forfeiture of $7.36 million

Enlarge / Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, exits federal court in the Brooklyn borough of New York on Friday, Aug. 4, 2017. (credit: Getty | Bloomberg)

The disgraced pharmaceutical executive and hedge fund manager Martin Shkreli must forfeit $ 7.36 million in assets (PDF) to the federal government following his fraud conviction, a judge ruled Monday. The assets set for forfeiture (PDF) include the single copy of the Wu-Tang album Once Upon A Time in Shaolin that Shkreli reportedly bought for $ 2 million, as well as a painting by Pablo Picasso.

The forfeiture follows Shkreli’s conviction last October on three of eight counts of securities and wire fraud. The federal government had indicted Shkreli in December of 2015 for running a Ponzi-like scheme, alleging he defrauded investors in two hedge funds he managed and siphoning millions from his pharmaceutical company, Retrophin, to cover losses.

But, despite the high-profile trial, Shkreli is best known for raising the price of a drug for parasitic infections by more than 5,000 percent—from $ 13.50 a pill to $ 750 a pill—while he was the CEO of Turing Pharmaceutical. The drug is often prescribed to babies and people with HIV/AIDS.

Read 5 remaining paragraphs | Comments

Post Author: martin

Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now. He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.